Figure 4From: Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer Top, Distant recurrence-free survival curves for all 28 patients according to whether or not they have 11p15.5 loss (A) and 8q21.13 gain (B). Bottom, Point plot and moving average (solid line) of representative samples showing 11p15.5 loss and 8q21.13 gain.Back to article page